Shanghai Labway Clinical Laboratory Co Ltd Working Capital to Net Assets Ratio
Shanghai Labway Clinical Laboratory Co Ltd working capital to net assets ratio. Shanghai Labway Clinical Laboratory Co Ltd (301060) has a Working Capital to Net Assets ratio of 75.5% as of March 2026. Working capital of CN¥1.27 Billion (current assets of CN¥1.83 Billion minus current liabilities of CN¥561.26 Million) is measured against net assets of CN¥1.68 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible net worth ratio of Shanghai Labway Clinical Laboratory Co L to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Shanghai Labway Clinical Laboratory Co Ltd (2013–2025)
Working capital to net assets ratio of Shanghai Labway Clinical Laboratory Co Ltd from 2013 to 2025. This chart shows how Shanghai Labway Clinical Laboratory Co Ltd's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the ratio stands at 75.5%, reflecting working capital of CN¥1.27 Billion against net assets of CN¥1.68 Billion CNY. See operational self-sufficiency of Shanghai Labway Clinical Laboratory Co L to measure how many days the company can operate on defensive assets alone.
Shanghai Labway Clinical Laboratory Co Ltd Working Capital to Net Assets Ratio by Year (2013–2025)
Shanghai Labway Clinical Laboratory Co Ltd working capital to net assets ratio by year from 2013 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Shanghai Labway Clinical Laboratory Co Ltd from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 301060 total assets.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 74.2% | CN¥1.22 Billion | CN¥1.64 Billion | CN¥1.75 Billion | CN¥531.18 Million | ▼ -1.8 pp |
| 2024 | 76.0% | CN¥1.38 Billion | CN¥1.82 Billion | CN¥2.00 Billion | CN¥615.59 Million | ▲ +0.0 pp |
| 2023 | 75.9% | CN¥1.50 Billion | CN¥1.98 Billion | CN¥2.33 Billion | CN¥822.83 Million | ▼ -11.0 pp |
| 2022 | 86.9% | CN¥1.97 Billion | CN¥2.27 Billion | CN¥3.39 Billion | CN¥1.41 Billion | ▲ +4.3 pp |
| 2021 | 82.6% | CN¥1.35 Billion | CN¥1.64 Billion | CN¥1.77 Billion | CN¥412.98 Million | ▼ -0.4 pp |
| 2020 | 83.0% | CN¥1.03 Billion | CN¥1.25 Billion | CN¥1.25 Billion | CN¥218.01 Million | ▲ +1.1 pp |
| 2019 | 81.8% | CN¥992.69 Million | CN¥1.21 Billion | CN¥1.17 Billion | CN¥178.55 Million | ▲ +5.6 pp |
| 2018 | 76.2% | CN¥900.04 Million | CN¥1.18 Billion | CN¥1.16 Billion | CN¥257.23 Million | ▲ +2.6 pp |
| 2017 | 73.6% | CN¥812.58 Million | CN¥1.10 Billion | CN¥1.03 Billion | CN¥220.68 Million | ▲ +4.4 pp |
| 2016 | 69.2% | CN¥425.53 Million | CN¥614.70 Million | CN¥754.77 Million | CN¥329.25 Million | ▼ -5.8 pp |
| 2015 | 75.0% | CN¥228.95 Million | CN¥305.25 Million | CN¥489.45 Million | CN¥260.50 Million | ▼ -2.9 pp |
| 2014 | 77.9% | CN¥156.65 Million | CN¥201.13 Million | CN¥415.89 Million | CN¥259.24 Million | ▲ +4.4 pp |
| 2013 | 73.4% | CN¥96.05 Million | CN¥130.79 Million | CN¥294.59 Million | CN¥198.54 Million | — |